CHARLESTON, S.C.

南卡罗来纳州查尔斯顿

,

，

Aug. 5, 2026

2026年8月5日

/PRNewswire/ -- Salus Scientific today announced the successful closing of its oversubscribed Series A financing, raising a total of

/美通社/ -- Salus Scientific 今日宣布，其超额认购的A轮融资已成功完成，共筹集资金

$10.1 million

1010万美元

. The company entered the round targeting $8.0 million, but investor demand proved substantially stronger, and the round closed above target and ahead of schedule.

该公司本轮融资目标为800万美元，但投资者需求远超预期，最终融资额超出目标并提前完成本轮融资。

The new capital gives Salus a durable runway to fund commercial scale-up, expand its production and clinical infrastructure, and carry the company through its revenue ramp.

新资本为Salus提供了持久的资金支持，以推动其商业化规模扩张、扩大生产和临床基础设施，并助力公司实现收入增长。

'We are pleased to have closed our Series A above target and ahead of schedule,' said

“我们很高兴能够超额且提前完成A轮融资，”

Todd Flohr, Chairman and Chief Executive Officer of Salus Scientific

萨卢斯科学公司董事长兼首席执行官托德·弗洛尔

. 'We are thrilled to welcome partners who understand our value proposition and align with the company's long-term vision. That the round closed oversubscribed is, in our view, a direct endorsement of both our commercial thesis and our execution discipline.'

“我们非常高兴能够欢迎那些理解我们的价值主张并与公司长期愿景相一致的合作伙伴。本轮融资超额认购，在我们看来，这直接证明了我们的商业逻辑和执行能力。”

About Salus Scientific

关于萨卢斯科学

Salus Scientific is building the occupational wellness platform for modern procedural medicine, redefining how healthcare organizations protect the physicians, technologists, and nurses who perform fluoroscopy-guided procedures.

Salus Scientific 正在为现代介入医学打造职业健康平台，重新定义医疗保健机构如何保护执行荧光透视引导手术的医生、技师和护士。

Media & Investor Contact

媒体与投资者联系

Keith Rosmarin

基思·罗斯马林

Chief Financial Officer

首席财务官

[email protected]

[email protected]

Forward-Looking Statements: This press release contains 'forward-looking statements,' including statements regarding the company's use of proceeds, growth strategy, and future capital requirements. These statements are not guarantees of future performance and involve risks and uncertainties that may cause actual results to differ materially.

前瞻性陈述：本新闻稿包含“前瞻性陈述”，包括有关公司资金用途、增长战略及未来资本需求的陈述。这些陈述并非对未来表现的保证，并涉及可能导致实际结果出现重大差异的风险和不确定性。

The company undertakes no obligation to update forward-looking statements except as required by applicable law..

除适用法律要求外，公司不承担更新前瞻性陈述的义务。

SOURCE Salus Scientific

来源：Salus Scientific

21

二十一

%

百分比

more press release views with

更多新闻稿浏览量，使用

Request a Demo

申请演示